secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sonoma Pharmaceuticals, Inc. (SNOA)
CIK:        0001367083
Form:       8-K
Filed at:   2025-08-29T23:59:59+00:00
Accession:  0001683168-25-006580
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Sonoma Pharmaceuticals shareholders elect director, approve executive compensation and auditor
--------------------------------------------------------------------------------

- Dr. Jay Birnbaum elected Class II director with 123,034 votes for, 19,478 withheld.
- Non-binding advisory vote to approve named executive officer compensation passed 112,548 for, 26,360 against, 3,604 abstain.
- Ratification of Frazier & Deeter as auditor for FY ending March 31, 2026 passed with 702,484 for, 13,569 against, 2,416 abstain.
- Adjournment proposal passed with 576,908 for, 140,513 against, 1,048 abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1367083/000168316825006580/0001683168-25-006580-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1367083/000168316825006580/sonoma_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-25-006580

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer